Discover how we're Innovating Reach

Annual Report 2025

Ranked #1 in India’s Pharma & Biotech Sector for Sustainability

Syngene is recognized by TIME Magazine and Statista as one of the "World's Most Sustainable Companies, 2025"

See How We Lead Sustainably

A Strategic Advancement

Clinical Development is Now Translational & Clinical Research Services (T&CR)

Click here to know more

Syngene's new biologics facility in the U.S.

New site to increase Syngene’s total single-use bioreactor capacity to 50,000 Liters

Click here to know more

Syngene Ramaiah Certificate Program in Sterile Manufacturing

Are you dreaming of getting a job in critical operations in pharma or biopharma companies?

+91-88848 99898 | admissions@bioconacademy.com

Apply now

Discover how we're Innovating Reach

Annual Report 2025

Read now

Ranked #1 in India’s Pharma & Biotech Sector for Sustainability

Syngene is recognized by TIME Magazine and Statista as one of the "World's Most Sustainable Companies, 2025 "

See How We Lead Sustainably

A Strategic Advancement

Clinical Development is Now Translational & Clinical Research Services (T&CR)

Click here to know more

Syngene's new biologics facility in the U.S.

New site to increase Syngene’s total single-use bioreactor capacity to 50,000 Liters

Click here to know more

Who we are

We are an innovation-led contract research, development and manufacturing organization offering integrated scientific services from early discovery to commercial supply.

What we do

We offer clients a customized end-to-end solution to fulfil their R&D and manufacturing requirements. Our approach enables us to forge client relationships that move beyond the traditional service outsourcing model into true end-to-end collaborations.

Discovery

Our Discovery Services span the entire spectrum of early stage research from target …

Development

Our Development Services encompass activities from pre-clinical to clinical trials…

Manufacturing

Our Manufacturing services include cGMP-compliant facilities for clinical supplies, registration batches…

Dedicated Centers

Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support…

InstaVisit – Visit Syngene virtually

Syngene InstaVisit is an interactive virtual experience designed to give you a 360 degree view of Syngene’s world-class facilities and capabilities. The platform allows you to change your perspective, look around and zoom in as we take you on a guided tour of Syngene’s labs.

View Now

0 +

Active Clients

Collaborations with top 20 Pharma/Biotech companies

5200

Scientists

Mn sq. ft. of R&D and manufacturing infrastructure

0 +

Patents

Latest News

View all

Syngene named one of the ‘World’s Most Sustainable Companies 2025’ by TIME Magazine & Statista

Press Release

3rd Jul, 2025

Strategic shifts position India as a pharma partner of choice

News

1st Jul, 2025

India enjoys a far greater degree of confidence in IP security for Western partners than does China

News

30th Jun, 2025

Insights

View all

Overcoming ADME Challenges in PROTAC Development: Key Insights from Syngene Experts

Targeted protein degraders like PROTACs offer novel therapeutic potential but face ADME hurdles—poor solubility, permeability, and weak IVIVC. Experts Prasoon Chaturvedi (C4 Therapeutics), Vishwottam Kandikere, and Amol Raje (Syngene) discussed solutions.

27 June 2025

Bridging the Unbridgeable: The Promise of PROTACs in Drug Discovery

Imagine a world where diseases once deemed “undruggable” are met with targeted, precise therapies. This vision is rapidly becoming a reality, thanks to the revolutionary technology of PROTACs (proteolysis-targeting chimeras).

27 June 2025

Paws, Pills and Progress – CRDMO’s pivotal role

As I stepped into the conference hall in Boston, I overheard an investor say, “The next billion-dollar biotech might just come from the animal health sector.

26 June 2025

Upcoming events

View all

Interphex Japan

July 9th-11th

Tokyo

CPhI South East Asia

July 16th-18th

Kuala Lampur

AVMA Convention

July 18th-22nd

Washington

Bio Asia Taiwan 2025

July 24th-27th

Taiwan

Spec and Agro Show

July 29th-31st

Georgia

Immuno Oncology Summit

August 11th-13th

Philadelphia

Corporate Social Responsibility

To strive towards developing and sustaining healthy and empowered communities by improving the quality of life.

Governance

Behind consistent growth is good governance

Careers

Discover a world of opportunities

Annual Reports

Touching a billon lives through innnovation

Discovery

Development

Manufacturing

Discovery

Development & Manufacturing

SynVent Integrated Drug Discovery

Emerging Biopharma

Dedicated Centers

Center for Advanced Protein Studies (CAPS)

Who we are

What we do

Discovery

Development

Manufacturing

Dedicated Centers

InstaVisit – Visit Syngene virtually

Latest News

Syngene named one of the ‘World’s Most Sustainable Companies 2025’ by TIME Magazine & Statista

Strategic shifts position India as a pharma partner of choice

India enjoys a far greater degree of confidence in IP security for Western partners than does China

Insights

Overcoming ADME Challenges in PROTAC Development: Key Insights from Syngene Experts

Bridging the Unbridgeable: The Promise of PROTACs in Drug Discovery

Paws, Pills and Progress – CRDMO’s pivotal role

Upcoming events

Corporate Social Responsibility

Governance

Careers

Annual Reports

Explore more

Blog

Instavisit

Webinar

Viewpoint

Get in touch

Sign-up for our newsletter

Quick links

Business

Get in touch

Other links

To view or email, Please share your details view

To download, Please share your details

To view or email, Please share your details view

To download, Please share your details